Core Viewpoint - Erkang Pharmaceutical experienced a significant increase in stock price, reaching a daily limit up of 20% with a turnover rate of 26.96% and a transaction volume of 1.644 billion yuan [2] Trading Activity - The stock was listed on the Shenzhen Stock Exchange due to its closing price increase of 20%, with net purchases from the Shenzhen Stock Connect amounting to 12.5195 million yuan [2] - The top five trading departments accounted for a total transaction volume of 438 million yuan, with a net purchase of 22.4406 million yuan after a buy transaction of 230 million yuan and a sell transaction of 208 million yuan [2] - The third largest buying department was the Shenzhen Stock Connect, with a buying amount of 41.7105 million yuan and a selling amount of 29.1910 million yuan, resulting in a net purchase of 12.5195 million yuan [2] Capital Flow - The stock saw a net inflow of 2.37 billion yuan from major funds, with a significant inflow of 2.55 billion yuan from large orders, while large orders experienced a net outflow of 172.329 million yuan [2] - Over the past five days, the net inflow of major funds totaled 2.52 billion yuan [2] Margin Trading Data - As of January 12, the margin trading balance for the stock was 259 million yuan, with a financing balance of 259 million yuan and a securities lending balance of 496,000 yuan [2] - Over the past five days, the financing balance decreased by 14.0384 million yuan, representing a decline of 5.15%, while the securities lending balance increased by 205,900 yuan, reflecting a growth of 70.96% [2]
尔康制药1月13日龙虎榜数据